COVID Vaccine Development was Astonishing, but Therapeutics Discovery and Development aren’t Solved
Our CSO and Co-Founder discusses the astounding pace of the COVID vaccine development and how we need to apply what we've learned to future R&D.
Synthace CEO on Scaling Innovative Companies and Accelerating Life Sciences
We asked our CEO Guy Levy-Yurista about his journey into biotech, his plans for Synthace & the steps he's taking to strengthen the company culture.
Veteran Technology Executive Joins Synthace to Accelerate Its Mission to Revolutionize the Life Science Research Market
Synthace hires Guy Levy-Yurista as Chief Executive Officer.
People of Synthace: Sarah James, PhD – Senior Technical Specialist
“We're constantly learning new things at Synthace. It's interesting to learn what our software engineers do & it's cool to teach them some biology!"
People of Synthace: Matthew Gregg – Team Lead (Miniaturized Purification)
“I’m proud of the enthusiasm & ethical stance Synthace has taken. It’s not just a market opportunity – it’s something that people really believe in."
People of Synthace: Moiz Ebrahimjee – Cell and Gene Therapy Business Development Manager
"Synthace is working on something revolutionary, and it's really exciting to be at the forefront of technology and science, in particular automation."
Synthace Appoints Dr. Nick Jurascheck as VP of Engineering
Dr. Jurascheck brings with him more than twenty years of experience spanning senior technology roles in high-tech product companies and consultancies.
People of Synthace: Vishal Sanchania, PhD – Head of Biology
“The way we do science needs to change. There needs to be a real embrace of digital tools - but frankly, I'm glad to be part of the revolution.”
People of Synthace: Adam Paton – Commercial Biologics Director
“We have a mission to disrupt and change the way people do biology. When we achieve this, we will have positively impacted many, many lives.”